Skip to content
TrustList
Funding news

IntelliProve raises EUR 2.7 million seed to take camera health sensing to humanoid robots

Editorial

By TrustList Editorial

Ghent software company IntelliProve has raised a EUR 2.7 million seed round led by Miles Ahead to take its camera-based health sensing, six biomarkers from a 30-second face scan, from virtual care apps to humanoid robots.

About IntelliProve raises EUR 2.7 million seed to take camera health sensing to humanoid robots

IntelliProve raises EUR 2.7 million seed to take camera health sensing to humanoid robots

19 November 2026: IntelliProve, a software company from Ghent in Belgium, has raised EUR 2.7 million in seed funding. The Belgian venture capital firm Miles Ahead leads the round, with the home care organisation The White and Yellow Cross (Wit-Gele Kruis in Dutch), imec.istart and several business angels taking part.

Not yet independently verified. This rests on IntelliProve's own announcement dated 19 November 2026, read the same day. Accuracy and validation claims are the company's own; the release states no medical device clearance, and we have not tested the product. No valuation was given. We will update this when it can be confirmed, and remove this note.

What the software does

IntelliProve sells what it calls a health sensing layer for any camera. A person looks into a phone or laptop camera for 30 seconds and the software returns six biomarkers: heart rate, heart rate variability, respiratory rate, systolic and diastolic blood pressure, and resonant breathing. No cuff or wearable is needed. Partners build the layer into their own apps under their own brand.

The method is remote photoplethysmography, or rPPG. Each heartbeat changes the colour of facial skin very slightly, too little for the eye to see but enough for a camera to measure, and small breathing movements are read the same way. The company says it has built its own technology to cope with movement, changing light and different cameras.

Where it is used today

Founded in 2021, IntelliProve works with TU Delft, Ghent University Hospital and The White and Yellow Cross. It says its ISO 27001-certified technology already runs in virtual care, health insurance and wellbeing platforms in more than 50 countries.

Why humanoid robots

The new money is meant to take the layer beyond phones and laptops. Because it is software that works with a standard camera, IntelliProve argues it can run in a humanoid robot as well. Joeri Tulkens, co-founder and co-CEO, said humanoid robots are becoming very good at understanding the world around them, and that the next step is helping them understand the people in it. The company points to ageing populations and staff shortages in care as the reason measurements that need a device, contact and a trained person do not scale.

For robot makers and care providers looking at assistive robots, the round shows camera-based vital signs being offered as a component rather than a separate device. The release names no robot maker as a customer yet, and buyers in clinical settings should ask which measurements carry medical device clearance in their market before relying on them.

Sources

Categories & features

TrustList Weekly

The week in software and IT, in one email

The news that matters to buyers, new rankings and our own research. Every Thursday, free, and easy to leave.

We will email you to confirm. Unsubscribe with one click in any issue. Privacy policy

You may be interested in